High Mobility Group Box 1 Gene Polymorphism and Serum High Mobility Group Box 1, Interleukin 1 Beta, and Alpha-Klotho Crosstalk in Severe COVID-19 Patients

CONCLUSION: The serum HMGB1, IL1β, and α-klotho may be severity markers and promising therapeutic targets for COVID-19 patients.PMID:38318856 | DOI:10.1080/08820139.2023.2299680
Source: Immunological Investigations - Category: Allergy & Immunology Authors: Source Type: research